Posted on 7/6/17
Johnson & Johnson: Where's The Growth Coming From?
Image creditJohnson & Johnson (JNJ) has long been a company that has many cash demands. It pays a sizable dividend, buys back stock by the billion . . .
Posted on 7/6/17
Endo To Sell SOMAR To Advent For $124M
Endo International plc (NASDAQ: ENDP) today announced it has entered into a definitive agreement to sell Mexico
Posted on 7/6/17
CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank
CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that on June 30, 2017 it received an additional $5 million . . .
Posted on 7/6/17
Egalet Announces Proposed Public Offering of Common Stock and Warrants
Egalet Corporation (Nasdaq: EGLT) a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, announced today that . . .
Posted on 7/10/17
Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene
SUMMIT, N.J. & BEIJING--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) and BeiGene, Ltd. (NASDAQ:BGNE) entered into a strategic collaboration to develop and commercialize BeiGene’s investigational anti-programmed cell death protein . . .
Posted on 7/5/17
Johnson & Johnson Needs More Actelions
Johnson & Johnson (JNJ) has long been a company that has many cash demands. It pays a sizable dividend, buys back stock by the billion and . . .
Posted on 7/5/17
Interview - Johnson & Johnson Breathes New Life Into Infectious Diseases
When Johnson & Johnson (NYSE:JNJ) highlighted 12 potential blockbusters from its pipeline in May there were a few on the list that raised eyebrows. Two of . . .
Posted on 7/5/17
MTBC Acquires Regional Revenue Cycle Management Company
MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services
Posted on 7/5/17
Better Buy: Pfizer Inc. vs. Eli Lilly and Company
Pfizer (NYSE:PFE) might be more than twice as big as fellow drugmaker Eli Lilly and Company (NYSE:LLY), but Lilly has been the better investment choice for . . .
Posted on 7/5/17
Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb
Big pharma stocks are arguably set to shine now that the threat of hard caps on drug prices is off the table. Global prescription drug sales, . . .
Posted on 7/5/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 27, 2017 it approved non-statutory stock options to purchase an aggregate of 74,750 shares of its . . .
Posted on 7/5/17
Geisinger Chief Medical Officer and Board Member Co-author New England Journal of Medicine Article on Hospital Wait Times
Jaewon Ryu, M.D., J.D., Geisinger executive vice president and chief medical officer, and Thomas H. Lee, M.D., Press Ganey chief medical officer and a member of . . .
Posted on 7/5/17
Ipsen Announces Dysport Co-Promotion Agreement with Saol Therapeutics
BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen SA (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that it has entered into an exclusive, three-year . . .
Posted on 6/29/17
A Look At The Competition Geron Could Face In Myelodysplastic Syndromes
Geron Corporation (GERN) has had a rather quiet 2017 so far. The last bit of good news we heard was the announcement that Johnson and Johnson's . . .
Posted on 6/29/17
The PNC Financial Services Group (PNC) Investor Presentation - Slideshow
The following slide deck was published by PNC Financial Services Group, Inc. in conjunction with this event. 131READ FULL ARTICLE HERE
Posted on 6/29/17
Merck's Cautious Statement Suggests Slim Chances Of Anacetrapib Success
On Tuesday, Merck & Co. (MRK) surprised the scientific community and investors when it announced that its Phase 3 REVEAL study succeeded. The Phase 3 study . . .
Posted on 6/29/17
2 Fastest Growing Biotech Stocks
Even though biotech has been sky-rocketing over the last five years, the industry's eye-popping growth spurt isn't showing any signs of slowing down. In fact, EvaluatePharma . . .
Posted on 6/29/17
5 Biotech Stocks With Major Catalysts in July
July brings fireworks and fun for many Americans. The month will also bring major catalysts for several biotechs. Those catalysts could provide a spark for the . . .
Posted on 6/29/17
Helius Medical Announces Closing of CAD$7.0 Million Private Placement
NEWTOWN, Pa., June 28, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT), a medical technology company focused on the treatment of neurological symptoms . . .
Posted on 6/28/17
Daniel Kubikian, DMD Named Top Dentist in Periodontics By Philadelphia Magazine, New Jersey Monthly and SJ Magazine
Daniel Kubikian DMD, Haddonfield resident and owner of South Jersey Periodontics and Dental Implants
Posted on 6/28/17
180 Degree Capital Corp.’s Portfolio Company, Mersana Therapeutics Completes IPO
MONTCLAIR, N.J., June 28, 2017 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) noted today that its portfolio company, Mersana Therapeutics, Inc., completed an initial public . . .
Posted on 6/28/17
Holy Redeemer Health System Brings Orthopedics to Feasterville
Holy Redeemer Health System announces the opening of Holy Redeemer Orthopedic Surgery, located at Holy Redeemer Health Care at 23 Bustleton Pike, Suite 300, Feasterville, PA. . . .
Posted on 6/28/17
PTC Therapeutics: The Star Is Rising
IntroductionPTC Therapeutics (PTCT) is a pharmaceutical company with expertise in Ribonucleic acid biology. The company has strategic collaborations with Roche and SMA Foundation for spinal muscular . . .
Posted on 6/28/17
Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc.
It looks like the good times will continue to roll for U.S. pharmaceutical stocks. The recently revealed draft of an executive order aims to lower drug . . .
Posted on 6/28/17
Jason Raines, DDS Named Top Dentist By New Jersey Monthly and South Jersey Magazine
Jason Raines DDS, owner of Raines Dental LLC in Mullica Hill, has been named one of the top dentists in the region by

